Microbial cell envelope and macromolecules

The microbial cell envelope and macromolecules represent a broad category of essential structural and functional components within microorganisms that serve as the primary targets for antimicrobial therapy. The cell envelope, which includes the cell wall (peptidoglycan) and the cytoplasmic membrane, provides structural integrity and protects the cell from osmotic lysis (StatPearls, 2023). Macromolecules such as DNA, RNA, and ribosomes are critical for the storage of genetic information, transcription, and protein synthesis, respectively (NIH, 2022). Antimicrobial drugs exploit the biochemical differences between these microbial structures and human cells to achieve selective toxicity. For example, beta-lactams and glycopeptides inhibit cell wall synthesis, while polymyxins disrupt membrane integrity (PubMed, 2021). Other classes, such as aminoglycosides and fluoroquinolones, target the machinery responsible for macromolecular synthesis, including the 30S/50S ribosomal subunits and DNA gyrase. Because this term encompasses a wide array of distinct molecular entities rather than a single receptor or enzyme, it is typically used as a classification for drug mechanisms of action in infectious disease management.

Other names

Bacterial cell envelopeMicrobial cell wall and membraneBacterial macromoleculesProkaryotic cell envelope

Inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis (30S/50S ribosome), and inhibition of nucleic acid synthesis (DNA gyrase/RNA polymerase).